|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/519 | |
| A61K 31/7068 | |||
| A61K 9/00 | |||
| A61P 35/00 | |||
| A61K 9/20 | |||
| A61K 9/48 |
| (11) | Patento numeris | 2654755 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 11851046.0 |
| Europos patento paraiškos padavimo data | 2011-12-20 | |
| (97) | Europos patento paraiškos paskelbimo data | 2013-10-30 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2016-08-17 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2011/066017 |
| Data | 2011-12-20 |
| (87) | Numeris | WO 2012/088030 |
| Data | 2012-06-28 |
| (30) | Numeris | Data | Šalis |
| 201061424961 P | 2010-12-20 | US |
| (72) |
DEMARINI, Douglas, J., US
LE, Ngocdiep, T., US
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | Combination therapy comprising Gemcitabine for the treatment of pancreatic cancer |
| Combination therapy comprising Gemcitabine for the treatment of pancreatic cancer |